Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

SmartInsider Aug. 20 at 12:46 PM

Pfizer Inc - $PFE on Aug 13th, 2026 Learn more: https://www.smartinsider.com/stock-of-the-week/pfe-us-ranked-positive-on-aug-13th-2026/ See disclaimer: https://www.smartinsider.com/disclaimer/

0 · Reply

La_Parka3 Aug. 20 at 12:31 PM

$MRNA $MRK $PFE Can someone please advise me on what I should do? I am an extremely masculine man who has been avoiding soy milk for years because I refuse to risk being called a soyboy. Now Moderna comes along with excellent cancer vaccine results, and I am intrigued. The problem is, I was deeply spooked by the sight of a needle during the pandemic-era vaccination campaign, and I am still carrying the resentment. I know I should be brave because I am, after all, a very manly man, but do I swallow my pride and enter the stock, or would that compromise my masculinity?

3 · Reply

Fliptax Aug. 20 at 12:24 PM

$MRNA time to take profit and put it into $CRON or $PFE

0 · Reply

jackofalltrade Aug. 20 at 12:19 PM

$PFE Pfizer really is working to kill cancer with ADCs, not just keep it away once you have gotten rid of it. Pfizer has 4 ADCs currently on the market with more on the way. Each ADC has 3 parts: The payload, a cancer-killing drug that destroys the cancer cells once delivered inside a cell A monoclonal antibody, a specially-designed protein that guides the ADC to the right target – cancer cells – while minimizing impact to healthy cells A linker, which connects the payload to the antibody. Once inside the cell, the linker breaks apart, releasing the payload and minimizing damage to healthy cells

0 · Reply

JuggernautRaider Aug. 20 at 12:18 PM

$NUVB $ALT $TLSA $PFE 🤩 😋 💨 💊 🏃‍♀️

0 · Reply

ItsCarRamRod Aug. 20 at 12:08 PM

$PFE Looks like a good start to give back ALL of yesterdays gains. Since PFE did not deserve the increase on its own merits.

0 · Reply

JuggernautRaider Aug. 20 at 11:37 AM

$BMY looking strong as a NJ pharma bond $PFE $NVS $JNJ too!!! 💫

0 · Reply

Outcomes Aug. 20 at 11:30 AM

$IBRX .....remember when $MRNA & $PFE were battling it out for jab dominance!? Remember patients first! https://www.reuters.com/legal/litigation/pfizer-wins-pause-modernas-covid-19-patent-lawsuit-2024-04-12/

0 · Reply

Jtlo Aug. 20 at 10:51 AM

$PFE this bitch is leaving with out me? I had shares at 21 sold - had shares at 24 paperhand on the bad news with the oncology read out - bourla insider trades??? What percentage of that buy is his total comp package? Is it that great?

1 · Reply

Batman9988 Aug. 20 at 10:41 AM

$MRNA $NVAX $PFE $TEM Congrats on those who made money the news but if you really think a pharmaceutical company is trying to cure cancer then you don't understand the business. Pharmaceutical are not in the business of curing diseases because then it eliminates customers. The news was the vaccine "in trials" reduces recurrence of melanoma it doesn't cure anything or completely stop it. The insiders knew the trial results just look at the options calls that were bought 😂

1 · Reply

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

2026-08-16T13:55:21.000Z - 3 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

2026-08-14T18:45:04.000Z - 5 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Aug 14, 2026, 1:45 PM EDT - 5 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 11:46 AM EDT - 5 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:11 AM EDT - 5 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

2026-08-14T13:47:35.000Z - 5 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Aug 14, 2026, 1:00 AM EDT - 6 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

2026-08-07T11:40:49.000Z - 13 days ago

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 14 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 15 days ago

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 7:24 AM EDT - 16 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 16 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 16 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Aug 4, 2026, 6:52 AM EDT - 16 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:45 AM EDT - 16 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Jul 30, 2026, 7:48 AM EDT - 21 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 6:45 AM EDT - 21 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 21 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 4 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 4 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 4 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 4 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 5 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 6 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 7 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 7 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

SmartInsider Aug. 20 at 12:46 PM

Pfizer Inc - $PFE on Aug 13th, 2026 Learn more: https://www.smartinsider.com/stock-of-the-week/pfe-us-ranked-positive-on-aug-13th-2026/ See disclaimer: https://www.smartinsider.com/disclaimer/

0 · Reply

La_Parka3 Aug. 20 at 12:31 PM

3 · Reply

Fliptax Aug. 20 at 12:24 PM

$MRNA time to take profit and put it into $CRON or $PFE

0 · Reply

jackofalltrade Aug. 20 at 12:19 PM

0 · Reply

JuggernautRaider Aug. 20 at 12:18 PM

$NUVB $ALT $TLSA $PFE 🤩 😋 💨 💊 🏃‍♀️

0 · Reply

ItsCarRamRod Aug. 20 at 12:08 PM

$PFE Looks like a good start to give back ALL of yesterdays gains. Since PFE did not deserve the increase on its own merits.

0 · Reply

JuggernautRaider Aug. 20 at 11:37 AM

$BMY looking strong as a NJ pharma bond $PFE $NVS $JNJ too!!! 💫

0 · Reply

Outcomes Aug. 20 at 11:30 AM

0 · Reply

Jtlo Aug. 20 at 10:51 AM

1 · Reply

Batman9988 Aug. 20 at 10:41 AM

1 · Reply

bikechain Aug. 20 at 9:30 AM

$PFE Especially if they’re confident in being the highest bidder for $SLS, the next Keytruda….and, about to finalize it’s P3 literally days away.

1 · Reply

PaulineBoudreaux971 Aug. 20 at 7:29 AM

$UBS $PFE $BKNG $TJX $UBER UBS benefits from global wealth management and investment-banking activity, Pfizer remains focused on its pharmaceutical pipeline, Booking Holdings benefits from global travel demand, TJX benefits from value-oriented consumer spending, and Uber benefits from mobility and delivery growth. I'm watching asset flows, clinical catalysts, travel bookings, retail sales, and mobility demand.

0 · Reply

The5ersFutures Aug. 20 at 6:55 AM

Can AI save the Pfizer growth engine? Micro Pfizer futures offer clean exposure to the post-vaccine pivot. Bourla is all-in on AI and computational biology for the next growth leg. Oncology focus, AI partnerships, and patent strength with BioNTech define the story. Micro sizing improves capital efficiency for the trade. $PFE is the underlying. Micro futures are the vehicle. $PFE #Pfizer #MicroFutures #AI #Biotech

0 · Reply

Diehard777 Aug. 20 at 6:33 AM

$PFE Pfizer CEO Albert Bourla purchased 38,000 shares of company stock on August 12, 2026, at an average price of $26.34 per share, totaling just over $1 million.Transaction DetailsDate: August 12, 2026Shares Purchased: 38,000Price Per Share: $26.34 Why before $MRNA news ??????????????????!!!!!!!!!!?????????????☺️ $SPY

0 · Reply

StonkFactor Aug. 20 at 4:59 AM

$PFE How long do you think until pfizer pulls the same move if they are talking about cancer vaccines.

0 · Reply

TalkMarkets Aug. 20 at 3:55 AM

Insider Watch: 3 CEOs Betting Millions On Their Own Stocks $INTC $PFE $CSGP https://talkmarkets.com/article/insider-watch-3-ceos-betting-millions-on-their-own-stocks-1787195613

0 · Reply

svb64 Aug. 20 at 3:01 AM

$PFE a little price appreciation to go along with the dividends. Looking for 30. Sector is back in favor

0 · Reply

Johnny_Lever Aug. 20 at 2:09 AM

$PFE Bullish pennant breakout.

0 · Reply

MrPfizer Aug. 20 at 1:37 AM

$PFE Theres absolutely no way pfizer would let moderna go up crazy like that off a phase 3 readout when pfizers pipeline is already the best in the buisness in on oncology. Pfizer will one up then soon and modernas ceo will claim theyre just doing that to undermine them

1 · Reply

MrPfizer Aug. 20 at 1:35 AM

$PFE What i wanna know is, moderna pumped 150 + on a phase 3 readout So if pfizer gets a phase 3 readout thats good from one of there drugs in the cancer and or weight loss are we gonna pump too ? Why the f does moderna always pump crazy off stuff that doesbt even generateva cash flow for them.

1 · Reply

powellpnd Aug. 20 at 12:40 AM

$MRNA quick buy our population control ticker because a tiny sample group of people didn't die when we injected them with a mystery cocktail that isn't for sake and we have zero revenue from, and is not fda approved (not that fda has mattered in 6 years because we bought the chairmen of the fda just like congress) $PFE Both straight trash See you at zero after theyre done with fauci

0 · Reply

powellpnd Aug. 20 at 12:22 AM

$MRNA trash. Fuck Modena and fuck $PFE Jab sheep Pumping 2x on something that's not even approved or being sold, gee where have I heard that before? Absolute fucking trash. Shorted earlier made 200 bucks lol. This pos will end up in the gutter in time. Today will go down in history as one of the biggest traps ever witnessed. Bulls, the stock is still down 57% in 5 years AFTER the move today 😆

2 · Reply

Market Cap	155.32B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.81
Forward PE	9.03
Profit Margin	12.42%
Debt to Equity Ratio	0.74

Volume	59,804,100
Avg Vol	44,610,465
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	92%
Beta	0.34
Analysts	Sell
Price Target	$28.60